Primary peritonectomy/HIPEC for disseminated peritoneal adenomucinosis achieves much lower recurrence rates and better survival than secondary procedures.
作者： K.J. Zhu , D.L. Morris
DOI: 10.1016/S1479-666X(09)80108-X
关键词:
摘要: Background: Two main treatment options are available for pseudomyxoma peritonei (PMP) and disseminated peritoneal adenomucinosis (DPAM) — incomplete cytoreductive (debulking) surgery peritonectomy with intraperitoneal chemotherapy. Several studies have demonstrated improved survival peritonectomy. This study analyses outcome following in patients undergoing a primary procedure compared to those who had previous debulks. Methods: Between April 1997 May 2008, 63 underwent DPAM 38 debulk(s) 25 Patients were followed-up at three- six-monthly intervals postoperatively, mean follow-up time of 21 34 months, respectively. Results: Mean was 109.8 months. debulks 49.2 months (p=0.027). Five-year 95.5% the group 67.5% debulk group. Conclusion: Disease recurrence after is significantly less frequent than secondary
thesurgeon.net
elsevier.com参考文章(21)
P.H. Sugarbaker, Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome Ejso. ,vol. 27, pp. 239- 243 ,(2001) , 10.1053/EJSO.2000.1038
Rasmy Loungnarath, Sylvain Causeret, Nadine Bossard, Mohamed Faheez, Annie-Claude Sayag-Beaujard, Cécile Brigand, François Gilly, Olivier Glehen, None, Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Diseases of The Colon & Rectum. ,vol. 48, pp. 1372- 1379 ,(2005) , 10.1007/S10350-005-0045-5
Paul H. Sugarbaker, Are There Curative Options to Peritoneal Carcinomatosis? Annals of Surgery. ,vol. 242, pp. 748- 750 ,(2005) , 10.1097/00000658-200511000-00023
Vic J. Verwaal, Henk Boot, Berthe M. P. Aleman, Harm van Tinteren, Frans A. N. Zoetmulder, Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Annals of Surgical Oncology. ,vol. 11, pp. 375- 379 ,(2004) , 10.1245/ASO.2004.08.014
Thomas J. Miner, Jinru Shia, David P. Jaques, David S. Klimstra, Murray F. Brennan, Daniel G. Coit, Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy Annals of Surgery. ,vol. 241, pp. 300- 308 ,(2005) , 10.1097/01.SLA.0000152015.76731.1F
Brigitte M. Ronnett, Hui Yan, Robert J. Kurman, Barry M. Shmookler, Lee Wu, Paul H. Sugarbaker, Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer. ,vol. 92, pp. 85- 91 ,(2001) , 10.1002/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R
Paul H. Sugarbaker, David Chang, Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Annals of Surgical Oncology. ,vol. 6, pp. 727- 731 ,(1999) , 10.1007/S10434-999-0727-7
Robert M. Smeenk, Vic J. Verwaal, Ninja Antonini, Frans A. N. Zoetmulder, Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Annals of Surgery. ,vol. 245, pp. 104- 109 ,(2007) , 10.1097/01.SLA.0000231705.40081.1A
Brendan J Moran, Thomas D Cecil, The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surgical Oncology Clinics of North America. ,vol. 12, pp. 585- 603 ,(2003) , 10.1016/S1055-3207(03)00026-7
J. Bryant, A. J. Clegg, M. K. Sidhu, H. Brodin, P. Royle, P. Davidson, Systematic review of the Sugarbaker procedure for pseudomyxoma peritonei. British Journal of Surgery. ,vol. 92, pp. 153- 158 ,(2005) , 10.1002/BJS.4862